Back
Viridian Therapeutics 10K Form
Sell
31
VRDN
Viridian Therapeutics
Last Price:
$15.91
Seasonality Move:
-10.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VRDN News And Ratings
See the #1 stock for the next 7 days that we like better than VRDN
VRDN Financial Statistics
Sales & Book Value
Annual Sales: | $302K |
---|---|
Cash Flow: | $-73.4M |
Price / Cash Flow: | 0 |
Annual Sales: | $5.96 |
Price / Book: | 2.69 |
Profitability
EPS (TTM): | -3.77000 |
---|---|
Net Income (TTM): | $-269.9M |
Gross Margin: | $789K |
Return on Equity: | -46.02% |
Return on Assets: | -41.91% |
Viridian Therapeutics Earnings Forecast
Key Viridian Therapeutics Financial Ratios
-
The Gross Profit Margin over the past 5 years for VRDN is 23.64%.
-
The Selling, General & Administrative Expenses for VRDN have been equal to 20,226.16% of Gross Profit Margin.
-
The Research & Development expenses have been 78,892.05% of Revenue.
-
The Net Earning history of VRDN is -89,387.09% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 8 years.
Viridian Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | VRDN |
Website: | viridiantherapeutics.com |
Debt
Debt-to-Equity Ratio: | 0.03 |
---|---|
Current Ratio: | 15.43 |
Quick Ratio: | 14.99 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
VRDN Technical Analysis vs Fundamental Analysis
Sell
31
Viridian Therapeutics (VRDN)
is a Sell
Is Viridian Therapeutics a Buy or a Sell?
-
Viridian Therapeutics stock is rated a SellThe current Viridian Therapeutics [VRDN] share price is $15.92. The Score for VRDN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.